We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
-20.08%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$3.29B
AUM Growth
+$417M
Cap. Flow
+$1.08B
Cap. Flow %
32.97%
Top 10 Hldgs %
41.34%
Holding
1,203
New
250
Increased
374
Reduced
203
Closed
334

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$60.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$60.3M
3
AAPL icon
Apple
AAPL
+$19.6M
4
DOCU
DocuSign
DOCU
+$15.3M
5
ADBE icon
Adobe
ADBE
+$13.8M

Sector Composition

Rank Sector Weight
1 Technology 3.47%
2 Communication Services 1.62%
3 Financials 1.5%
4 Healthcare 0.95%
5 Industrials 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNS
851
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$169K 0.01%
35,000
CLRB icon
852
Cellectar Biosciences
CLRB
$19.3M
$162K ﹤0.01%
1,333
HPE icon
853
Hewlett Packard
HPE
$63.2B
$160K ﹤0.01%
+12,045
New +$183K
CZOO
854
CALL
DELISTED
Cazoo Group Ltd
CZOO
$112K ﹤0.01%
77
-175
-69% -$576K
UNIT
855
Uniti Group
UNIT
$2.63B
$94K ﹤0.01%
10,000
CCL icon
856
PUT
Carnival Corporation Ltd
CCL
$36.1B
$90K ﹤0.01%
10,400
+5,100
+96% +$74.8K
UA icon
857
Under Armour Class C
UA
$2.92B
$87K ﹤0.01%
+11,518
New +$130K
YTRA icon
858
Yatra Online
YTRA
$54.7M
$48K ﹤0.01%
21,200
APLT
859
DELISTED
Applied Therapeutics
APLT
$47K ﹤0.01%
+50,000
New +$81.9K
CELG.RT
860
Bristol-Myers Squibb Rights
CELG.RT
$47K ﹤0.01%
67,856
MILE
861
DELISTED
Metromile, Inc. Common Stock
MILE
$29K ﹤0.01%
+31,427
New +$32.1K
SUNL.WS
862
DELISTED
Sunlight Financial Holdings, Inc. Warrants, exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SUNL.WS
$15K ﹤0.01%
40,000
FFAIW
863
DELISTED
Faraday Future Intelligent Electric Warrant
FFAIW
$11K ﹤0.01%
24,537
BNZIW icon
864
Banzai International Warrant
BNZIW
$4K ﹤0.01%
39,782
HPX.WS
865
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$4K ﹤0.01%
45,474
A icon
866
CALL
Agilent Technologies
A
$39.1B
-100
Closed -$13K
A icon
867
PUT
Agilent Technologies
A
$39.1B
-3,200
Closed -$423K
ABBV icon
868
AbbVie
ABBV
$458B
-2,751
Closed -$420K
ACT icon
869
Enact Holdings
ACT
$6.53B
-50,000
Closed -$1.11M
ADM icon
870
PUT
Archer Daniels Midland
ADM
$41.4B
-600
Closed -$54K
AFL icon
871
CALL
Aflac
AFL
$63.9B
-300
Closed -$19K
AKAM icon
872
PUT
Akamai
AKAM
$16.8B
-1,500
Closed -$179K
ALGN icon
873
CALL
Align Technology
ALGN
$12B
-1,200
Closed -$523K
ALLO icon
874
Allogene Therapeutics
ALLO
$601M
-50,600
Closed -$461K
AME icon
875
PUT
Ametek
AME
$55.5B
-2,700
Closed -$360K

Similar funds

Maven Securities's Q2 2022 Portfolio in Review

As of Q2 2022, Maven Securities held 1,203 positions worth $3.29B, up 15% from $2.87B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Maven Securities deployed $1.08B of net new capital in Q2 2022, opening 250 new positions and adding to 374 existing holdings. Its largest new stake was Apple: 129,157 shares worth $17.7M.

By sector, the portfolio is most concentrated in Technology at 3.5% of assets, up from 1.6% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was ADMA Biologics, an estimated $5.95M trimmed.

  • Maven Securities's largest Q2 2022 buy was Apple: 129,157 shares worth $17.7M.
  • Maven Securities added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $60.7M increase.
  • Maven Securities's biggest Q2 2022 reduction was ADMA Biologics, cutting an estimated $5.95M.
  • Maven Securities fully exited Apellis Pharmaceuticals in Q2 2022, selling an estimated $11.2M.
  • Maven Securities's ten largest holdings make up 41% of its $3.29B portfolio in Q2 2022.
  • Maven Securities opened 250 new positions and closed 334 in Q2 2022.
  • Maven Securities's portfolio value rose 15% quarter-over-quarter to $3.29B.

Based on Maven Securities's 13F filing for Q2 2022, filed 15 Aug 2022.